We deliver turnkey, high-productivity bioprotein plants. Our proprietary non-foaming platform operates globally, tailored to regional gas compositions and market demands.
Unlike modern startups with unscaled laboratory ideas, our team builds upon the massive industrial heritage of the USSR, where 12 large-scale biochemical plants produced over 1.1 million tons of microbial protein annually. We took this historically proven industrial engineering and elevated it with our proprietary modern genetic platform.
We adapt our biological platform to the specific resources and economics of your region, maximizing ROI and solving localized food supply challenges.
Transform low-cost domestic gas into high-value premium feed. Our thermotolerant biological platform reduces cooling costs, making it highly competitive in arid climates.
Southeast Asia is the world's aquaculture hub. Our protein, rich in natural immuno-stimulating nucleotides, is the perfect premium substitute for increasingly scarce fishmeal.
Secure domestic food independence. Benefit from low domestic gas prices, extensive agricultural markets, and specialized state subsidies for industrial biotechnology.
Global competitors use complex U-Loop reactors and heavy defoamers to battle foaming. We solved this complex problem biology-first.
Our team is led by the original co-author of the revolutionary G2026 platform patent. We are developing a next-generation, even more productive non-foaming strain, engineered to adapt perfectly to hot climates (optimal performance at temperatures up to 43–45°C).
Because our strain does not produce sticky extracellular exometabolites, we use simple, highly reliable bubble column and jet-aerated fermenters instead of energy-draining U-Loop systems. This reduces CapEx by 30% and OpEx by 25%.
Our research team, in collaboration with the G.K. Skryabin Institute of Biochemistry and Physiology of Microorganisms, Russian Academy of Sciences, published a comprehensive genomic characterization of our high-yield, non-foaming G2026 platform strain. This peer-reviewed study confirms the molecular-genetic mechanisms of its exceptional productivity and foaming resistance.
Microbiology, 2026, Vol. 95, No. 4, pp. 482–495. Authors: V.M. Kramarenko, V.N. Khmelenina, et al.
Choose your target market and adjust parameters to see real-time dynamic projections based on verified regional financial models.
*Calculations are aligned with local models (Russia №674 / Algeria №676). Capital expenditures assume complete utility infrastructure connections.
While basic bioprotein serves the massive animal feed market, our platform includes technologies to fractionate biomass into high-value specialty components, boosting the joint venture's profitability.
Metanotrophic bacteria are natural super-producers of Vitamin B12. High-purity extraction generates pure pharma-grade cobalamin.
Extracted nucleic acids act as natural immunostimulants, accelerating cell growth in premium start feeds for aquaculture.
Enzymatic hydrolysis splits proteins into highly digestible hypoallergenic peptides for clinical and sports nutrition.
Connect directly with our senior scientific, engineering, and investment team. We welcome inquiries from commercial feed manufacturers, energy operators, government authorities, and strategic investors worldwide.
Our executive engineering and partnership team has received your request and will contact you via email shortly.
